The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Tessmer James F since year 2005.
The trader's CIK number is 1434095.
At the time of the last reporting, Tessmer James F was the VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc. .
(stock ticker symbol LXRX).
See this page for all insider trading activities at Lexicon Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-02||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||10,000||1.14||11,399|
|2019-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||10,226||.00||0|
|2018-06-08||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||10,000||10.15||101,500|
|2018-06-08||LXRX||Lexicon Pharmaceuticals, Inc.||Sale||10,000||12.91||129,080|
|2018-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||7,353||.00||0|
|2017-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||6,939||.00||0|
|2016-06-06||LXRX||Lexicon Pharmaceuticals, Inc.||Sale||1,500||15.00||22,500|
|2016-06-06||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||1,500||6.23||9,345|
|2016-05-23||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||6,000||6.23||37,380|
|2016-05-23||LXRX||Lexicon Pharmaceuticals, Inc.||Sale||6,000||13.00||78,000|
|2016-02-29||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||5,828||.00||0|
|2015-03-02||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||29,625||.00||0|
|2014-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||20,250||.00||0|
|2013-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||14,250||.00||0|
|2013-01-31||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||13,200||.00||0|
|2012-02-28||LXRX||Lexicon Pharmaceuticals, Inc.||Option Ex||7,500||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tessmer James F (VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.